A new product aims to make breast cancer screening available to everyone – even women in low resource settings. The World Health Organization estimates that breast cancer survival rates are below 40% in low-income countries, while it is over 80% in N. America, Sweden and Japan. The difference is due to lack of early detection programs in developing countries. UE Lifesciences has an answer to this problem: iBreast Exam – a point-of-use wireless scanner that is easy to use, inexpensive and totally portable. It works by assessing differences in tissue elasticity between malignant and non-cancerous breast tissue. The sensors in the hand-held device measure shear stiffness and tissue compression when applied to the skin. Clinical trials in India have produced good results. The award winning company has an infrared scanner for use in conventional clinical settings as well.
We are happy to alert you to products such as iBreast Exam that are examples of innovative and cost-effective medical advances. For more information:
